Australia investigates possible link of blood clot case to AstraZeneca vaccine
Gulf Times
Australian media reported that a 44-year-old man was admitted to a Melbourne hospital with possible clotting days after receiving the vaccine.
Australia is investigating whether a blood clotting disorder case recorded on Friday is related to the AstraZeneca coronavirus vaccine, Deputy Chief Medical Officer Professor Michael Kidd said. Australian media reported that a 44-year-old man was admitted to a Melbourne hospital with possible clotting days after receiving the vaccine. “Investigators have not at this time confirmed a causal link with the Covid-19 AstraZeneca vaccine, but investigations are ongoing,” Kidd told a televised briefing. He added that more details are expected to be known on Saturday.More Related News